EcoDrugPlus

Cyclin Dependent Kinase 9

Ensembl ID : ENSCLAG00000008361
Gene Symbol: CDK9
2 Cross references
207 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSCLAG00000009273
Gene Symbol: CDA
2 Cross references
232 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSCLAG00000001479
Gene Symbol: LOC102005856
1 Cross references
623 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSCLAG00000001437
Gene Symbol: LOC102007382
1 Cross references
664 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSCLAG00000000920
Gene Symbol: CYP17A1
2 Cross references
211 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSCLAG00000012685
Gene Symbol: CYP19A1
3 Cross references
319 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSCLAG00000010048
Gene Symbol: CYP26A1
3 Cross references
208 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSCLAG00000015567
Gene Symbol: CYP46A1
2 Cross references
260 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSCLAG00000011328
Gene Symbol: DGAT1
2 Cross references
262 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSCLAG00000005365
Gene Symbol: DHFR
2 Cross references
353 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSCLAG00000003204
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSCLAG00000009825
Gene Symbol: DPYD
3 Cross references
225 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).